Cannabinoids and Their Use for Chronic Pain – Cannabinoids as an Alternative to Opioids for Chronic Pain
Cannabinoids, Chronic Pain, Analgesics, Opioids
Haroutounian Simon, Ratz Yael, Ginosar Yehuda, et al. The Effect of Medicinal Cannabis on Pain and Quality-of-Life Outcomes in Chronic Pain: A Prospective Open-Label Study. The Clinical Journal of Pain. Volume 32 (12), December 2016, p 1036–1043. 10.1097/AJP.0000000000000364.
Kroenke, Kurt, MD; Cheville, Andrew, MD. Management of Chronic Pain in the Aftermarth of the Opioid Backlash. JAMA. 2017; 317 (23): 2365-2366. Doi: 10.1001/jama.2017.4884.
Philippe Lucas. Cannabis as an Adjunct to or Substitute for Opiates in the Treatment of Chronic Pain. Journal of Psychoactive Drugs Volume 44, 2012. 08 June 2012. http://dx.doi.org/10.1080/02791072.2012.684624
Beal, Benjamin; Wallace, Mark. An Overview of Pharmacologic Management of Chronic Pain. Medical Clinics of North America, 2016-01-01, Volume 100, Issue 1.
Wilsey Barth, Marcotte Thomas, Deutsch Reena. Low-Dose Vaporised Cannabis Significantly Improves Neuropathic Pain. The Journal of Pain. Volume 14, Issue 2. Feb 2013. http://www.sciencedirect.com/science/article/pii/S1526590012008644
Andreae Michael H, Carter George M, Shaparin Naum, et all. Inhaled Cannabis for Chronic Neuropathic Pain: A Meta Analysis of Individual Patient Data. The Journal of Pain. Volume 16 Issue 12. December 2015. https://doi.org/10.1016/j.jpain.2015.07.009
Lee Michael, Ploner Markus, Wiech Katja. Amygdala activity contributes to the dissociative effect of cannabis on pain perception. PAIN Volume 154, issue 1, Jan 2013. https://doi.org/10.1016/j.pain.2012.09.017
Berengere Houze, Hejar El-Khatib, Caroline Arbour. Efficacy, tolerability, and safety of non-pharmacological therapies for chronic pain: An umbrella review on various CAM approaches. Progress in Neuro Psychopharmacology and Biological Psychiatry. Volume 79, Part B. 3 October 2017. https://doi.org/10.1016/j.pnpbp.2017.06.035
Blake Alexia, Wan Bo Angela, Malek Leila. A selective review of medical cannabis in cancer pain management. Annals of Palliative Medicine. http://apm.amegroups.com/article/view/16199. 2017.
Grotenhermen F, Müller-Vahl K. The therapeutic potential of cannabis and cannabinoids. Dtsch Arztebl Int 2012; 109: 495-501.
Kahan Meldon, Srivastasva Anita, Spithoff Sheryl, Bromley Lisa. Prescribing smoked cannabis for chronic noncancer pain. Canadian Family Physician December 2014, 60 (12) 1083-1090.
Andresen SR, Biering-Sorensen F, Hagen EM, et al. Cannabis use in persons with traumatic spinal cord injury in Denmark. J Rehabil Med. 2017 Jan 31; 49 (2): 152-160. doi: 10.2340/16501977-2105.
Hasandeep Singh, Sakshi Bhushan, Rohit Arora, et al. Alternative treatment strategies for neuropathic pain: Role of Indian medicinal plants and compounds of plant origin-A review. Biomedicine & Pharmacotherapy. Volume 92, August 2017. https://doi.org/10.1016/j.biopha.2017.05.079
Lin LA, Bohnert ASB, Jannausch M, et al. Use of non-pharmacological strategies for pain relief in addiction treatment patients with chronic pain. American Journal on Addictions 2017 26: 6 (564-567).
Knishkowy, Barry. Medical cannabis for pain in adolescence. Journal of Pain Management, suppl. Special Issue: Cannabis; Hauppauge 9.4 (2016): 415-421.
Fitzcharles M. A., Baerwald C, Albin J. Efficacy tolerability and safety of cannabinoids in chronic pain associated with rheumatic diseases (fibromyalgia syndrome and rheumatoid arthritis): A systematic review of randomised controlled trials. Schmerz 2016 30: 1 (47-61)
Zajicek JP, Hobart, JC, Slade A, et al. Multiple sclerosis and extract of cannabis: results of the MUSEC trial. J Neurol Neurosurg Psychiatry. 2012 Nov; 83 (11): 1125-32. doi: 10.1136/jnnp-2012-302468. Epub 2012 Jul 12.
Kral AH, Wenger L, Novak SP, et al. Is cannabis use associated with less opioid use among people who inject drugs? Drug Alcohol Depend. 2015 Aug 1; 153: 236-41. doi: 10.1016/j.drugalcdep.2015.05.014. Epub 2015 May 22.
Goldenberg Matthew, Reid Mark, IsHak Waguih. The impact of cannabis and cannabinoids for medical conditions on health-related quality of life: A systematic review and meta-analysis. Drug and Alcohol Dependence. Volume 174, 1 May 2017. https://doi.org/10.1016/j.drugalcdep.2016.12.030
Boehnke Kevin, Litinas Evangelos, Clauw Daniel. Medical Cannabis Use is Associated With Decreased Opiate Medication Use in a Retrospective Cross-Sectional Survey of Patients With Chronic Pain. The Journal of Pain. Volume 17, issue 6, June 2016. https://doi.org/10.1016/j.jpain.2016.03.002.
Ware Mark, Wang Tongton, Shapiro Stan, et al. Cannabis for the Management of Pain: Assessment of Safety Study (COMPASS). The Journal of Pain, Volume 16, Issue 12, December 2015. https://doi.org/10.1016/j.jpain.2015.07.014
Khaiser Minhaz, Peng Meiko, Ahrari Soha. Medical Cannabis dosing strategies in pain-related conditions: A scoping review of current literature. Journal of Pain Management, suppl. Special Issue: Cannabis; Hauppauge 9.4 (2016): 449-463.
Temple Leslie. Medical marijuana and pain management. Disease-a-Month, Volume 62, Issue 9. September 2016. https://doi.org/10.1016/j.disamonth.2016.05.014
Adverse effects of cannabis. Prescrire Int. 2011 Jan; 20 (112): 18-23. PMID: 21462790
Klugman A, Gruzelier J. Chronic cognitive impairment in users of “ecstasy” and cannabis. World Psychiatry. 2003; 2 (3): 184-190.
Rabner J, Gottlieb S, Lazdowsky L, et al. Psychosis following traumatic brain injury and cannabis use in late adolescence. Am J Addict. 2016 Mar; 25 (2): 91-3. doi: 10.1111/ajad.12338. Epub 2016 Feb 5.
Shah Arya, Craner Julia, Cunningham Julie. Medical cannabis use among patients with chronic pain in an interdisciplinary pain rehabilitation program: Characterization and treatment outcomes. Journal of Substance Abuse Treatment. Volume 77, June 2017. https://doi.org/10.1016/j.jsat.2017.03.012
Burnett Amy. The Adverse effects of cannabis use in adolescents. Journal of Pain Management, suppl. Special Issue: Cannabis; Hauppauge 9. 4 (2016): 423-425.
Blanco C, Ogburn E, de los Cobos JP, et al. DSM-IV criteria-based clinical subtypes of cannabis use disorders: Results from the National Epidemiological Survey on Alcohol and Related Conditions (NESARC). Drug and alcohol dependence. 2008; 96 (0): 10.1016/j.drugalcdep.2008.02.008. doi: 10.1016/j.drugalcdep.2008.02.008.
Desjardins N, Jamoulle O, Taddeo D, Stheneur C. Cannabinoid Hyperemesis Syndrome in a 17-Year-Old Adolescent. J Adolesc Health. 2015 Nov; 57 (5): 565-7. doi: 10.1016/j.jadohealth.2015.07.019. Epub 2015 Sep 12.